GLP-1 Medications: A New Era in Diabetes and Weight Loss Treatment Over the past decade, GLP-1 receptor agonists have transformed the treatment of type 2 diabetes and obesity. These medications not only help lower blood sugar but also promote significant weight loss and reduce the risk of cardiovascular disease in many patients. If you’ve heard…
GLP-1 for Weight Loss: How It Works, Benefits, Side Effects & Safety Dr. Moxit Shah, DM Endocrinology | Endocrinologist in Ahmedabad Weight loss is not simply a matter of willpower. Hunger, appetite regulation, insulin resistance, sleep, genetics and other metabolic factors can make long-term weight management difficult. GLP-1-based medicines have changed medical weight management by…
GLP-1 medications such as tirzepatide and semaglutide are transforming obesity treatment. Learn how they work, who can benefit, expected weight loss, potential side effects, and why expert guidance from Dr. Moxit Shah, Endocrinologist in Ahmedabad, is essential for safe and lasting results.
Thinking of stopping Mounjaro or Ozempic after weight loss or improved diabetes control? Before you stop, it’s important to understand what may happen to your appetite, body weight, and blood sugar levels. In this blog, Dr. Moxit Shah, Endocrinologist in Ahmedabad, explains the possible effects of stopping semaglutide or tirzepatide, including weight regain, increased hunger, and worsening sugar control, and how to stop these medicines safely under expert guidance.
By Dr. Moxit Shah, Endocrinologist, Ahmedabad What is Yurpeak? Yurpeak is a once-weekly injectable medication containing tirzepatide, one of the most effective modern treatments for both obesity and type 2 diabetes. It is marketed in India by Cipla under an agreement with Eli Lilly and is available in a convenient KwikPen device. Tirzepatide has gained…
By Dr. Moxit Shah, Endocrinologist & Diabetes Specialist, Ahmedabad Introduction Weight loss medicines such as Mounjaro (tirzepatide), Ozempic (semaglutide), Wegovy, and other GLP-1 receptor agonists have revolutionized obesity treatment. These medications can help patients lose significant amounts of weight, improve blood sugar control, reduce fatty liver disease, and lower cardiovascular risk. However, like all medications,…
Introduction One of the most common questions patients ask before starting Mounjaro (tirzepatide) is: “How long will I need to take Mounjaro?” Many people assume that Mounjaro is a short-term weight loss treatment. However, obesity and type 2 diabetes are chronic medical conditions, and understanding the expected treatment duration is essential for long-term success. In…
GLP-1 specialist in Ahmedabad: Dr. Moxit Shah provides medically supervised Weight Loss and Type 2 Diabetes treatment with appropriate GLP-1 therapies, including Semaglutide and Tirzepatide.
By Dr Moxit Shah,Endocrinologist In Ahmedabad With the arrival of Mounjaro, Ozempic, Wegovy, and multiple generic semaglutide brands in India, patients now have more treatment options than ever before for diabetes, obesity, and weight loss. One of the most common questions I hear in my endocrinology clinic is: “Which is cheaper: Mounjaro, Ozempic, or generic…
